IX MOLECULAR
CYTOPATHOLOGY

ACROSS THE OCEAN

VIRTUAL MEETING

3rd / 4th DECEMBER 2020

Organized by

Giancarlo Troncone
Sinchita Roy-Chowdhuri
Maria D. Lozano

 

Organizing Secretariat

Concerto Srl
Tel  + 39 081.19569195
E-mail: info@concertosrl.net

 

With the Patronage of:

Selected Highlights from “The IX Molecular Cytopathology Meeting”

Because of COVID-19 and keeping the health and safety of our attendees as our top priority, this year’s annual meeting will be delivered in a virtual format.

For the past several years, the International Molecular Cytopathology Meeting held annually in Naples, Italy, has focused on providing a perspective on the evolution of molecular pathology in the field of cytopathology with updates on cytological and molecular classifications. This year with the virtual format of the Ninth Molecular Cytopathology Meeting, we are aiming to provide a more diverse and international perspective to the practice of molecular cytopathology with participation from across the world.

The meeting will be held as two half-day sessions, a morning session in the US that will correspond to an afternoon session in Europe, to allow maximum participation from most countries.

Day 1 of the meeting will feature sessions on Thyroid, Pancreatobiliary, Salivary Gland, Lung and and a special session on COVID-19;

Day 2 will feature sessions on Cervical cytology, Urine, Serous Fluid and Breast, Immunocytochemistry.

Each session will be introduced by a Moderator presenting an update on the cytological classification followed by one or two presentations on the molecular updates on the same topic. Each session will be followed by an interactive discussion session, including the moderator and speakers, responding to and discussing questions and comments from the global audience. With the virtual format, we are hoping for a novel and unique way to make this meeting as interactive as possible and give the audience a chance to engage with the speakers.

PROGRAM

Program according to CET (Central European Time)
Pacific Time (PT): Los Angeles -9 hrs
Central Time (CT):  Chicago -7 hrs
Eastern Time (ET): New York -6 hrs

3rd DECEMBER 2020

 

INTRODUCTION

2.30 PM Introduction to IX MOLECULAR CYTOPATHOLOGY ACROSS THE OCEAN

Giancarlo Troncone
Sinchita Roy-Chowdhuri 
Maria D. Lozano

SESSION I: COVID-19 session

2.50 PM Introduction: Epidemic implication for Molecular Cytopathology
G. Troncone

3.10 PM Cytology in the Time of Coronavirus Disease (covid-19): An Italian Perspective
E. Vigliar

SESSION II: Molecular Thyroid Cytopathology

3.30 PM Introduction: The indeterminate thyroid cytopathology: what’s new from TBSRTC, second edition
Z.W. Baloch

3.50 PM Molecular Cytopathology for Thyroid Nodules: A Review of Methodology and Test Performance
M. Nishino

4.10 PM Interventional molecular thyroid cytopathology. From the FNA to the NGS at the University Federico II of Naples
C. Bellevicine

4.30 PM Questions & Answers

SESSION III: Molecular Pancreatobiliary Cytopathology

4.40 PM Introduction: Standardized Terminology and Nomenclature for Pancreatobiliary Cytology: The Papanicolaou Society of Cytopathology Guidelines
L.J. Layfield

5.00 PM Guidelines for Pancreaticobiliary Cytology from the Papanicolaou Society of Cytopathology: the contribution of molecular tests
M. Pitman

5.20 PM Questions & Answers

SESSION IV: Ancillary Testing in Salivary Gland Cytology

5.30 PM Introduction: The Milan System for Reporting Salivary Gland Cytopathology: Considerations From Theory to Practice
E.D. Rossi

5.50 PM The place for molecular tests in the Milan System for Reporting Salivary Gland Cytopathology
W.C. Faquin

6.00 PM Questions & Answers

SESSION V: Lung

6.10 PM Introduction: Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies: Guideline from American College of Pathologists
S. Roy-Chowdhuri

6.30 PM What is new in lung biomarker testing: implication for cytology and liquid biopsy specimens
P. Hofman

6.50 PM Challenges and Opportunities of cfDNA Analysis Implementation in Clinical Practice: focus on lung cancer
U. Malapelle

7.10 PM Questions & Answers

4th DECEMBER 2020

SESSION I: Cervical cytology

2.30 PM Introduction: Cervical Cytology in the era of molecular screening
G. Negri

2.50 PM The 2019 ASCCP Risk management guidelines for cervical cancer screening
R. Nayar

3.10 PM Questions & Answers

SESSION II: Ancillary testing in urine cytology

3.20 PM Introduction: The Paris System for Reporting Urine Cytology: Considerations From Theory to Practice
G.A. Barkan   

3.40 PM UroVysion® FISH Assay and risk-stratification using the Paris System for Reporting Urine Cytology
E.M. Wojcik

3.50 PM Questions & Answers

SESSION III: Serous fluid cytopathology

4.00 PM Introduction: Development of the International System for Reporting Serous Fluid Cytopathology
A. Chandra

4.20 PM Toward the International System for Reporting Serous Fluid Cytopathology: how to incorporate molecular data in our cytopathology reports
F.C. Schmitt 

4.40 PM Questions & Answers

SESSION IV: Breast cytology

4.50 PM Introduction: The International Academy of Cytology Yokohama System for Reporting Breast FNAB: Introduction and Overview
P. Vielh

5.10 PM A tale of two needles. Core- versus fine-needle in the era of molecular cytopathology
F.C. Schmitt

5.30 PM Questions & Answers

SESSION V: Immunocytochemistry

5.40 PM Introduction and Moderator
L. Bubendorf

6.00 PM Comprehensive predictive testing (NGS and ICC) on   Pap-stained cytology 
S. Savic

6.20 PM Challenges of ICC and FISH in the field of targeted therapies. From cell block to smears
M.D. Lozano 

6.40 PM Questions & Answers

7.00 PM Closing remarks

FACULTY

Zubair W. Baloch

MD, PhD
Philadelphia, Pennsylvania – USA

Professor of Pathology and Laboratory Medicine
University of Pennsylvania Medical Center- Perelman School of Medicine

Güliz A. Barkan

MD, FIAC
Maywood, Illinois – USA

Professor of Pathology and Urology
Vice Chair of Education Cytopathology Fellowship Program Director
Director of Cytopathology Loyola University Healthcare System

Claudio Bellevicine

MD, PhD
Naples – Italy

Assistant Professor of Anatomic Pathology,
Department of Public Health, University of Naples Federico II

Lukas Bubendorf

MD
Basel – Switzerland

Professor, Institute of Pathology
University Hospital Basel

Ashish Chandra

MD, FRCPath, DipRCPath (Cytol)
London – United Kingdom

Consultant Pathologist Lead for Cytopathology & Urological Histopathology
St Thomas’ hospital London

William C. Faquin

MD, PhD
Boston, Massachusetts – USA

Professor of Pathology,
Harvard Medical School & Massachusetts General Hospital

Paul Hofman

MD, PhD
Nice – France

Professor of Pathology, Laboratory of Clinical and Experimental Pathology
University Côte d’Azur, Nice

Lester J. Layfield

MD
Columbia, Missouri – USA

Medical Student Coordinator, OSA IVPathology and Anatomical Sciences Dept. University of Missouri

Maria D. Lozano

MD, PhD, MIAC
Pamplona – Spain

Professor of Pathology, Director Department Of Pathology
Clinica University of Navarra

Umberto Malapelle

PhD
Naples – Italy

Chief Supervisor of Predictive Molecular Pathology Lab, Department of Public Health, University of Naples Federico II

Ritu Nayar

MD
Chicago, Illinois – USA

Professor of Pathology and Medical Education
Vice Chair for Education and Faculty Development, Department of Pathology Northwestern University, Feinberg School of Medicine, Chicago

Giovanni Negri

MD, PhD, MIAC
Bolzano – Italy

Pathology Unit Central Hospital Bolzano

Michiya Nishino

MD, PhD
Boston, Massachusetts – USA

Director, Head&Neck Pathology Beth Israel Deaconess Medical Center
Assistant Professor of Pathology Harvard Medical School

Martha Pitman

MD
Boston, Massachusetts – USA

Professor of Pathology Harvard Medical School

Esther D. Rossi

MD, PhD
Rome, Italy

Aggregate professor of Anatomic Pathology
Fondazione Policlinico Universitario Agostino Gemelli. IRCCS

Sinchita Roy-Chowdhuri

MD, PhD
Houston ,Texas – USA

Assistant Professor Department of Pathology, UT M.D. Anderson Cancer Center

Spasenija Savic Prince

MD – Pathology (FMH) Cytopathology
Basel – Switzerland

Senior pathologist, Institute for Medical Genetics and Pathology University Hospital Basel

Fernando C. Schmitt

MD, PhD, FIAC, IFCAP
Porto – Portugal

Professor of Pathology at Medical Faculty of Porto University Head, Molecular Pathology Unit, IPATIMUP, General Secretary of the International Academy of Cytology,  President of the International Society of Breast Pathology

Giancarlo Troncone

MD, PhD
Naples – Italy

Full Professor of Anatomic Pathology, Department of Public Health, University of Naples Federico II

Philippe Vielh

MD, PhD, FIAC
Paris – France

Medipath and American Hospital of Paris

Elena Vigliar

MD, PhD
Naples – Italy

Assistant Professor of Anatomic Pathology, Department of Public Health, University of Naples Federico II

Eva M. Wojcik

MD
Maywood, Illinois – USA

Professor and Chair, Department of Pathology and Laboratory Medicine Loyola University Medical Center

The world of molecular cytopathology: Predictive testing and precision medicine.
Highlights from the VIII International Molecular Cytopathology Meeting in Naples, Italy

Concerto Srl
Tel  + 39 081.19569195
E-mail: info@concertosrl.net
www.concertosrl.net